OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
31
Results
Show all
Save search
Copy query
Show results for
Unknown
(31)
Publication Date
Release Date
2022
(8)
2021
(5)
2025
(4)
2023
(3)
2024
(2)
2020
(2)
2019
(2)
2018
(2)
2017
(2)
2016
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
Not available
S-EPMC7837033
|
biostudies-literature
Cite
MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome.
Not available
S-EPMC5670038
|
biostudies-literature
Cite
Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Not available
S-EPMC6620379
|
biostudies-literature
Cite
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
Not available
S-EPMC6117612
|
biostudies-literature
Cite
A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
Not available
S-EPMC5223093
|
biostudies-literature
Cite
IRF2BPL Is Associated with Neurological Phenotypes.
Not available
S-EPMC6081494
|
biostudies-literature
Cite
'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
Not available
S-EPMC7320935
|
biostudies-literature
Cite
Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.
Not available
S-EPMC9669819
|
biostudies-literature
Cite
New insights into the genetic etiology of Alzheimer's disease and related dementias.
Not available
S-EPMC9005347
|
biostudies-literature
Cite
Stroke genetics informs drug discovery and risk prediction across ancestries.
Not available
S-EPMC9524349
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets